Morgan Stanley raised the firm’s price target on Macerich (MAC) to $20 from $19 and keeps an Equal Weight rating on the shares. Management said on the Q4 earnings call in February that they expect to provide an updated “Path Forward Plan 3.0” at the upcoming NAREIT conference on June 1-4, the analyst noted.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MAC:
- Scotiabank upgrades Macerich to Outperform on ‘meaningful catalysts’
- Macerich upgraded to Outperform from Sector Perform at Scotiabank
- Macerich price target raised to $19 from $18 at JPMorgan
- Macerich Highlights Strong Leasing Momentum and Path Forward Progress
- Macerich price target raised to $17 from $15 at Goldman Sachs